Northern Trust’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $71.8M | Buy |
880,029
+73,753
| +9% | +$5.33M | 0.01% | 987 |
|
|
2026
Q1 | $54.9M | Buy |
806,276
+36,856
| +5% | +$2.61M | 0.01% | 1045 |
|
|
2025
Q4 | $58.4M | Buy |
769,420
+31,851
| +4% | +$2.31M | 0.01% | 1016 |
|
|
2025
Q3 | $45.3M | Sell |
737,569
-1,622
| -0.2% | -$84.5K | 0.01% | 1201 |
|
|
2025
Q2 | $36.1M | Sell |
739,191
-4,820
| -0.6% | -$229K | 0.01% | 1294 |
|
|
2025
Q1 | $37.9M | Buy |
744,011
+16,035
| +2% | +$800K | 0.01% | 1256 |
|
|
2024
Q4 | $32.9M | Buy |
727,976
+52,714
| +8% | +$2.26M | ﹤0.01% | 1390 |
|
|
2024
Q3 | $25.1M | Buy |
675,262
+16,803
| +3% | +$563K | ﹤0.01% | 1478 |
|
|
2024
Q2 | $20.1M | Sell |
658,459
-16,542
| -2% | -$536K | ﹤0.01% | 1559 |
|
|
2024
Q1 | $19.6M | Sell |
675,001
-13,846
| -2% | -$388K | ﹤0.01% | 1608 |
|
|
2023
Q4 | $19M | Sell |
688,847
-2,346
| -0.3% | -$53.6K | ﹤0.01% | 1648 |
|
|
2023
Q3 | $15.5M | Buy |
691,193
+5,061
| +0.7% | +$188K | ﹤0.01% | 1718 |
|
|
2023
Q2 | $27.9M | Buy |
686,132
+29,269
| +4% | +$1.43M | 0.01% | 1371 |
|
|
2023
Q1 | $31.8M | Buy |
656,863
+5,150
| +0.8% | +$235K | 0.01% | 1240 |
|
|
2022
Q4 | $24.9M | Buy |
651,713
+4,102
| +0.6% | +$171K | 0.01% | 1403 |
|
|
2022
Q3 | $32.5M | Sell |
647,611
-7,958
| -1% | -$390K | 0.01% | 1141 |
|
|
2022
Q2 | $26.3M | Sell |
655,569
-16,754
| -2% | -$587K | 0.01% | 1350 |
|
|
2022
Q1 | $25.1M | Sell |
672,323
-36,300
| -5% | -$1.4M | ﹤0.01% | 1516 |
|
|
2021
Q4 | $28.2M | Sell |
708,623
-5,758
| -0.8% | -$220K | ﹤0.01% | 1532 |
|
|
2021
Q3 | $26.6M | Sell |
714,381
-21,105
| -3% | -$867K | ﹤0.01% | 1589 |
|
|
2021
Q2 | $31.1M | Buy |
735,486
+5,568
| +0.8% | +$239K | 0.01% | 1563 |
|
|
2021
Q1 | $34.6M | Sell |
729,918
-48,389
| -6% | -$2.87M | 0.01% | 1422 |
|
|
2020
Q4 | $47.5M | Sell |
778,307
-23,290
| -3% | -$1.37M | 0.01% | 1115 |
|
|
2020
Q3 | $37.5M | Sell |
801,597
-37,747
| -4% | -$1.86M | 0.01% | 1116 |
|
|
2020
Q2 | $42.6M | Buy |
839,344
+54,583
| +7% | +$2.68M | 0.01% | 1012 |
|
|
2020
Q1 | $35M | Buy |
784,761
+19,015
| +2% | +$957K | 0.01% | 1008 |
|
|
2019
Q4 | $36.8M | Buy |
765,746
+8,720
| +1% | +$371K | 0.01% | 1237 |
|
|
2019
Q3 | $25.6M | Buy |
757,026
+74,794
| +11% | +$3.26M | 0.01% | 1482 |
|
|
2019
Q2 | $30.7M | Buy |
682,232
+12,454
| +2% | +$492K | 0.01% | 1373 |
|
|
2019
Q1 | $25.2M | Buy |
669,778
+79,551
| +13% | +$2.67M | 0.01% | 1488 |
|
|
2018
Q4 | $20.3M | Sell |
590,227
-172,111
| -23% | -$6.19M | 0.01% | 1573 |
|
|
2018
Q3 | $35.8M | Buy |
762,338
+25,446
| +3% | +$1.05M | 0.01% | 1299 |
|
|
2018
Q2 | $24.9M | Buy |
736,892
+71,756
| +11% | +$2.24M | 0.01% | 1598 |
|
|
2018
Q1 | $18M | Sell |
665,136
-2,521
| -0.4% | -$63.9K | ﹤0.01% | 1765 |
|
|
2017
Q4 | $11.1M | Sell |
667,657
-9,573
| -1% | -$162K | ﹤0.01% | 2118 |
|
|
2017
Q3 | $13.6M | Buy |
677,230
+62,134
| +10% | +$1.22M | ﹤0.01% | 2003 |
|
|
2017
Q2 | $11.3M | Buy |
615,096
+48,308
| +9% | +$651K | ﹤0.01% | 2090 |
|
|
2017
Q1 | $5.58M | Buy |
566,788
+3,231
| +0.6% | +$39.1K | ﹤0.01% | 2490 |
|
|
2016
Q4 | $6.15M | Buy |
563,557
+16,489
| +3% | +$173K | ﹤0.01% | 2414 |
|
|
2016
Q3 | $7.66M | Buy |
547,068
+90,461
| +20% | +$735K | ﹤0.01% | 2237 |
|
|
2016
Q2 | $3.21M | Buy |
456,607
+54,073
| +13% | +$397K | ﹤0.01% | 2753 |
|
|
2016
Q1 | $3.06M | Sell |
402,534
-25,470
| -6% | -$442K | ﹤0.01% | 2735 |
|
|
2015
Q4 | $13.9M | Buy |
428,004
+8,295
| +2% | +$244K | ﹤0.01% | 1765 |
|
|
2015
Q3 | $11.2M | Buy |
419,709
+81,235
| +24% | +$3.47M | ﹤0.01% | 1919 |
|
|
2015
Q2 | $16.3M | Buy |
338,474
+35,370
| +12% | +$2.06M | ﹤0.01% | 1746 |
|
|
2015
Q1 | $18.4M | Buy |
303,104
+16,959
| +6% | +$1.03M | 0.01% | 1644 |
|
|
2014
Q4 | $14.8M | Buy |
286,145
+22,768
| +9% | +$1M | ﹤0.01% | 1766 |
|
|
2014
Q3 | $11.6M | Buy |
263,377
+104,813
| +66% | +$3.28M | ﹤0.01% | 1927 |
|
|
2014
Q2 | $4.14M | Buy |
158,564
+8,554
| +6% | +$183K | ﹤0.01% | 2649 |
|
|
2014
Q1 | $3.92M | Buy |
150,010
+18,488
| +14% | +$497K | ﹤0.01% | 2709 |
|
|
2013
Q4 | $2.23M | Buy |
131,522
+87,136
| +196% | +$1.53M | ﹤0.01% | 3087 |
|
|
2013
Q3 | $953K | Buy |
+44,386
| New | +$771K | ﹤0.01% | 3346 |
|
Other funds holding PTCT
RI
JT
Northern Trust's PTCT Position: Q2 2026 in Review
Northern Trust increased its PTC Therapeutics (PTCT) stake by 9.1% in Q2 2026, buying an estimated $5.33M and bringing the position to 880,029 shares worth $71.8M. The position accounts for 0.01% of the portfolio, ranked #987.
Northern Trust first reported a position in PTCT in Q3 2013 and has held it in 52 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Northern Trust held 880,029 shares of PTC Therapeutics worth $71.8M as of Q2 2026.
- Northern Trust bought 73,753 PTC Therapeutics shares in Q2 2026, an estimated $5.33M.
- PTC Therapeutics made up 0.01% of Northern Trust's portfolio in Q2 2026, its #987 holding.
- Northern Trust first reported a position in PTC Therapeutics in Q3 2013 and has held it in 52 quarters since.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.